Vol 26, No 1 (2021)
Technical note
Published online: 2021-01-22

open access

Page views 894
Article views/downloads 924
Get Citation

Connect on Social Media

Connect on Social Media

Gonadal-sparing total body irradiation with the use of helical tomotherapy for nonmalignant indications

Khaled Dibs1, Austin J. Sim2, Jose A. Penagaricano2, Kujtim Latifi2, Genevieve A. Garcia2, Julia A. Peters2, Michael L. Nieder3, Sungjune Kim2, Timothy J. Robinson24
Rep Pract Oncol Radiother 2021;26(1):153-158.


Background: The aim was to demonstrate the feasibility and technique of gonadal sparing total body irradiation (TBI) with helical tomotherapy. Total body irradiation is a common part of the conditioning regimen prior to allogeneic stem cell transplantation. Shielding or dose-reduction to the gonads is often desired to preserve fertility, particularly in young patients undergoing transplant for non-malignant indications. Helical tomotherapy (HT) has been shown to be superior to traditional TBI delivery for organ at risk (OAR) doses and dose homogeneity.

Materials and methods: We present two representative cases (one male and one female) to illustrate the feasibility of this technique, each of whom received 3Gy in a single fraction prior to allogeneic stem cell transplant for benign indications. The planning target volume (PTV) included the whole body with a subtraction of OARs including the lungs, heart, and brain (each contracted by 1cm) as well as the gonads (testicles expanded by 5 cm and ovaries expanded by 0.5 cm).

Results: For the male patient we achieved a homogeneity index of 1.35 with a maximum and median planned dose to the testes of 0.53 Gy and 0.35 Gy, respectively. In-vivo dosimetry demonstrated an actual received dose of 0.48 Gy. For the female patient we achieved a homogeneity index of 1.13 with a maximum and median planned dose to the ovaries of 1.66 Gy and 0.86 Gy, respectively.

Conclusion: Gonadal sparing TBI is feasible and deliverable using HT in patients with non-malignant diseases requiring TBI as part of a pre-stem cell transplant conditioning regimen.

Article available in PDF format

View PDF Download PDF file


  1. Litoborska J, Piotrowski T, Jodda A, et al. Evolution of treatment planning and dose delivery methods during radiotherapy for patients undergoing bone marrow transplantation: a review. Nukleonika. 2020; 65(1): 19–30.
  2. Stephens SJ, Thomas S, Rizzieri DA, et al. Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity. Adv Radiat Oncol. 2016; 1(4): 272–280.
  3. Borg M, Hughes T, Horvath N, et al. Renal toxicity after total body irradiation. Int J Radiat Oncol Biol Phys. 2002; 54(4): 1165–1173.
  4. Sanghvi PR, Kaurin DGL, McDonald TL, et al. Testicular shielding in low-dose total body irradiation. Bone Marrow Transplant. 2007; 39(4): 247–248.
  5. Springer A, Hammer J, Winkler E, et al. Total body irradiation with volumetric modulated arc therapy: Dosimetric data and first clinical experience. Radiat Oncol. 2016; 11: 46.
  6. Peñagarícano J, Moros E, Corry P, et al. Pediatric craniospinal axis irradiation with helical tomotherapy: patient outcome and lack of acute pulmonary toxicity. Int J Radiat Oncol Biol Phys. 2009; 75(4): 1155–1161.
  7. Peñagarícano JA, Chao M, Van Rhee F, et al. Clinical feasibility of TBI with helical tomotherapy. Bone Marrow Transplant. 2011; 46(7): 929–935.
  8. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005(34): 12–17.
  9. Hall EJ, Giaccia AJ. Clinical response of normal tissue. In: Hall EJ, Giaccia AJ. ed. Radiobiology for the Radiologist. Seventh ed. Wiliams & Wilkins, Philadelphia 2012.
  10. Wallace WHB, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003; 18(1): 117–121.
  11. Hui SK, Kapatoes J, Fowler J, et al. Feasibility study of helical tomotherapy for total body or total marrow irradiation. Med Phys. 2005; 32(10): 3214–3224.
  12. Feygelman V, Opp D, Javedan K, et al. Evaluation of a 3D diode array dosimeter for helical tomotherapy delivery QA. Med Dosim. 2010; 35(4): 324–329.
  13. Wong JYC, Filippi AR, Dabaja BS, et al. Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys. 2018; 101(3): 521–529.
  14. Litoborska J, Piotrowski T, Malicki J. Evaluation of three VMAT-TMI planning methods to find an appropriate balance between plan complexity and the resulting dose distribution. Phys Med. 2020 [Epub ahead of print]; 75: 26–32.
  15. Vriesendorp HM. Aims of conditioning. Exp Hematol. 2003; 31(10): 844–854.
  16. Van Dyk J, Galvin JM, Glasgow GP, Podgorsak EB. The Physical Aspects of Total and Half Body Photon Irradiation: A Report of Task Group 29 Radiation Therapy Committee. American Association of Physicists in Medicine, New York 1986.

Reports of Practical Oncology and Radiotherapy